High on-chip gain spiral Al 2 O 3 :Er 3+ waveguide amplifiers
Optics Express · 22.04.2024 · 32 (9) · 15527
DOI: 10.1364/oe.516705 ↗Kurz gefasst
Fachartikel in der Zeitschrift Optics Express, online erschienen am 12.04.2024. Verfasst von D B Bonneville und 3 weiteren Autor:innen. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Horizon 2020 Framework Programme.
Abstract (Originalsprache)
We demonstrate reactively sputtered Al 2 O 3 :Er 3+ waveguide amplifiers with an erbium concentration of 3.9 × 10 20 ions/cm 3 , capable of achieving over 30 dB small signal net gain at 1532 nm using bidirectional pumping at 1480 nm. We observe on chip output powers of 10.2-13.6 dBm of amplified signal power at 1532 nm for a 12.9 cm waveguide amplifier considering -25.4 dB of lumped coupling losses per facet. Annealing was used to improve the performance of the devices, which were patterned using electron beam lithography and reactive ion etching. This result, to our knowledge, represents record breaking on-chip internal net gain for Al 2 O 3 :Er 3+ waveguide amplifiers, which show promise over other technologies due to wafer scalability and promise of easy monolithic integration with other material platforms to support a wide variety of applications.
Förderung
- Horizon 2020 Framework Programme
Zitieren
APA
Bonneville, D. B., Osornio-Martinez, C. E., Dijkstra, M., & García-Blanco, S. M. (2024). High on-chip gain spiral Al 2 O 3 :Er 3+ waveguide amplifiers. Optics Express, 32(9), 15527. https://doi.org/10.1364/oe.516705
Vancouver
Bonneville DB, Osornio-Martinez CE, Dijkstra M, García-Blanco SM. High on-chip gain spiral Al 2 O 3 :Er 3+ waveguide amplifiers. Optics Express. 2024;32(9):15527. doi:10.1364/oe.516705
BibTeX
@article{Bonneville2024,
author = {Bonneville, D B and Osornio-Martinez, C E and Dijkstra, M and García-Blanco, S M},
title = {High on-chip gain spiral Al 2 O 3 :Er 3+ waveguide amplifiers},
journal = {Optics Express},
year = {2024},
volume = {32},
number = {9},
pages = {15527},
doi = {10.1364/oe.516705}
}
EUVIMED